Vol. t55, No. 2, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 700-708
September 15, 1988
EVIDENCE
FOR
THE
PRESENCE OF ANP-PRECURSOR IN THE RAT THYMUS
MATERIAL
Angelika M. Vollmar and R~diger Schulz Institut fur Pharmakologie, Toxikologie Universit~t M~nchen, K6niginstr. 16, D-8000
und Pharmazie, M ~ n c h e n 22, FRG
Received August 3, 1988
Acidic extraction of the thymus from two day old rats followed by purification on Sephadex G-50 gel filtration revealed the presence of atrial natriuretic peptide-like material (IR-ANP) by radioimmunoassay. Verification of the obtained immunoreactivity has been achieved by the use of two different types of antisera, i.e. two antisera directed against ANP (99-126), the other antiserum recognizing the Nterminal fragment (11-37) of the precursor ANP (1-126) molecule. In addition, reverse phase high performance liquid chromatography (RP-HPLC) and high performance gel permeation chromatography (HP-GPC) monitored by the three antisera have been employed for analysis of the extracted IR-ANP. In both systems the IR-ANP corresponded to the 15 kDa-ANP molecule (i-126) . Furthermore, by using immunohistochemical techniques a distinct localization of the IR-ANP material could be demonstrated. The outer cortical area of the thymus, containing mostly lymphoid cells, showed extensive immunostaining with the three different antisera. The data reported here indicate that the rat thymus is a source of ANP. © 1988 A c a d e m i c Press, Inc.
Mammalian
myocytes
synthesis review ANP
of
see
(99-126) in
glands
(4,5).
functional ANP tide.
natriuretic
influences
kidney,
on
ANP receptors, suggesting report
be
the
the
peptide
agreed salt
blood some
and
the
water and
these
site
(ANP)
that
vessels of
major
of (for
released
balance
by
the
adrenal
organs,
bearing
also seem to be able to synthetize additional
functions
for
of specific ANP receptors
this
pep-
on rat thy-
(9) implies that the thymus may be added to the list
of organs
ANP
to
is generally
Apparently,
A recent
on which
finding
tissue.
considered
atrial It
(3)
the
(6,7,8),
mocytes this
the
1,2).
acting
are
may
Indeed,
precursor
ANP
even
acts.
In analogy
suggest
the
the data communicated (1-126)
is
0006-291X/88 $1.50 Copyright © 1988 by Academic Press, Inc. All rights of reproduction in any form reserved.
present
700
with
presence in
other
of ANP
here propose the
rat
organs, in
this
that the
thymus,
and
Vol. 155, No. 2, 1988
might therefore
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
indicate that this peptide has a role in the
immunsystem.
MATERIALS AND METHODS Tissue extraction The thymus was removed from 20 two day old male Sprague Dawley rats under a dissection microscope immediately after decapitation and transfered into ice cold 0.1N HCI (2.5 ml). The tissue was homogenized by use of a ground glass homogenizer (10--20 strokes) at 4°C, and protein concentration was d e t e r m i n e d by the Bradford method (i0) (Bio-Rad kit, Munich, FRG). After boiling the homogenate for 60 sec in a m i c r o w a v e oven, it was centrifuged at 20000 x g for 20 min. The clear supernatant (2 ml) was extracted by adsorption to activated Amberlite XAD-4 adsorbens resin (250 mg per column) (Serva, Heidelberg, FRG). Elution was carried out with 2.5 ml 80% acetonitrile in 0.1% trifluoroacetic acid and lyophilized.
Chromatoqraphic analysis of the thymus extracts i.
Gelfiltration (GF): For further purification, the lyophilized tissue extract was dissolved in 200 ~i 0.1M acetic acid, centrifuged and the supernatant applied to a Sephadex G-50 (Pharmacia, Uppsala, Sweden) column (9 mm x i000 mm, Abimed, DUsseldorf, FRG). The flowrate was i0 ml 0.1N acetic acid per h. Calibration was carried out with bovine serum albumin (Vo) , vitamin BI2 (Vt) , rat-proANP (2-126) and rat-ANP (99-126). IR-ANP fractions (2.5 ml), detected by RIA, were pooled and lyophilized.
2.
Hiqh performance gel permeation chromatoqraphy (HPGPC):. An aliquot of the pooled IR-ANP fractions from t h e GF run was applied to a Spherogel TM TSK, 2000 SW column (i0 ~m, 7.5 mm x 300 mm; Beckmann Instruments, San Ramon, CA, USA), and eluted with 0.09% TFA containing 0.005M Na2SO4, 0.002M NaH2PO 4 and 30% acetonitrile (flowrate: 0.3 ml/min). Cal~bration was performed with the standards described above. Fractions (0.3 ml) were lyophilized and tested for IR-ANP by three different antisera (see RIA procedure).
3.
Reverse phase hiqh performance liquid c h r o m a t o q r a p h y (RP-HPLC): An aliquot of the lyophilized IR-ANP fractions from the GF ~in was redissolved in 25 ~i 0.1% TFA and loaded onto a HPLC C18 ODS Ultrasphere TM column (5 ~m, 4.6 mm x 2500 mm, Beckman Instruments, San Ramon, USA). Calibration of the column was performed with rat-ANP (103-.123), rat-ANP (103-126), rat-ANP (99-126) and ratpro-ANP (2-126). Elution was carried out with a linear gradient of acetonitrile (20-55%, 55 min) in 0.1% TFA (flowrate 1.5 ml/min). Fractions (1.5 ml) were again assayed with three different antisera by RIA. 701
Vol. 155, No. 2, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Antisera and radioimmunoassay procedures Different types of rabbit polyclonal employed in measuring ANP-like material:
antibodies
were
i.
Antisera raised against the carboxy-terminal sequence of ANP: a) antiserum "Toni III", previously described (ii), was raised against human-ANP (99-126), and b) antiserum "Loisl" was raised against rat-ANP (99-126). Antiserum "Toni III" recognizes the carboxy-terminus of ANP (99-126), showing crossreactivity with ANP (103126), but almost none with ANP (103-125) and ANP (103123). It crossreacts with rat-ANP (99-126) to 82%. A n t i s e r u m "Loisl" is directed against the ring epitope of rat-ANP (99-126), not reacting with the human-ANP (99-126) (1%). Rat and human material differ in only one amino acid (position ii0) situated in the ring structure. Both antisera ("Toni III" and "Loisl") do not detect the N-terminal fragment ANP (1-30) (unpublished results), but crossreact with rat-pro-ANP (2-126) to 30% and 48%, respectively.
2.
A n t i s e r u m "GT-23" has been characterized (12). Briefly, it was generated against rat-ANP (11-37), a fragment of the N-terminal sequence of the ANP molecule (1-126). This antiserum does not recognize ANP (99-126), but shows 100% crossreactivities to N-terminal sequence fragments like human-ANP (1-30), human-ANP (11-37), rat-ANP (1-98) and rat-ANP (1-126).
The radioimmunoassays, employing antiserum "Toni III" and "~Q~sl", were performed as described (ii), except using [izDI]-rat-ANP (99-126) and cold rat-ANP (99-126) instead of the human-ANP (99-126). The RIA procedure for the N-terminal fragments of rat-proANP has been reported el~w~here (13). Human-ANP (1-30) was used as standard and the[ z I]-ANP (1-30) as tracer.
Recovery experiments Duplicates of 20 thymus glands were homogenized in 2.5 ml PBS, using a glass potter and incubated for 2 h at 37°C in order to digest endogenous IR-ANP material. IN HCl was then added to adjust the pH to i. 1 pmol synthetic rat-pro-ANP (2-126) was added to one of the acidic tissue homogenates and the extraction and chromatographic procedures were performed as described. The concentration of IR-ANP was measured by the two RIA systems in the homogenate with or without added pro-ANP, and the values obtained for the amount of pro-ANP (2-126) were corrected for the corresponding crossreactivity of the antiserum ("Toni III" and "GT-23", respectively) used.
Immunohistochemistr7 3-5 mm thick sections of the thymus were fixed in Bouin's fluid for 3 h at 4°C. The tissues were dehydrated in graded alcohols, cleared in xylene and embedded in Paraplast. 702
Vol. 155, No. 2, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Slices (5 ~m) were cut (Leitz microtome, Munich, FRG) and mounted on acid-cleaned, gelatin chrome alumn coated slides. Endogenous peroxidase was inhibited by preincubation of sections with methanol, containing 0.3% H202. Sections were then processed for immunohistochemis~ry with either antiserum "Toni III", "Loisl" or "GT-23". Before applying the primary antisera, sections were preincubated with goat serum (1:30) for 20 min at 25°C to reduce unspecific binding. Primary antibodies ("Toni III", "Loisl" and "GT23", respectively) were applied in a i:i00 dilution for 12 h at 4°C followed by an incubation with goat-anti-rabbit IgG (1:50, Sigma, Munich, FRG) for 30 min at 25°C. Finally, a rabbit peroxidase anti-peroxidase (PAP) (1:200, P-L Biochemicals, Inc., Milwaukee, WI, USA) was applied for 1 h at 25°C. All antisera were diluted in 0.i M PBS containing 1% goat serum and 0.1% BSA. After extensive rinsing with PBS, sections were incubated with a fresh solution of ethylcarbazol (0.3 mg/ml) in 0.i M acetate buffer (pH 5.2) containing 0.003% H202. Controls included incubation with rabbit preimmune serum (i:i00), use of primary antisera previously adsorbed with either synthetic rat-ANP (5 ~g/100 ~i PBS), or rat-pro-ANP (2-126) (25 ~g/100 ~i PBS) for 12 h at 4°C, and omission of the primary antisera, goat-antirabbit IgG, or PAP, respectively. Unless otherwise stated, all these controls gave negative results.
Materials:
[125I]-rat-ANP (99-126) was purchased ~Kom Amersham (Braunschweig, FRG). Human-ANP (1-30) and [~z°I]-human-ANP (1-30) were from Peninsula Labs (Belmont, CA, USA); rat-ANP (103123), rat-ANP (103-126), human- and rat-ANP (99-126) from Novabiochem (L~ufelfingen, Sitzerland). Rat-pro-ANP (2-126) was kindly provided by Drs. Sch6ne, Preibisch and Seipke (Hoechst AG, Frankfurt, FRG). All other reagents were purchased from Sigma (Taufkirchen, FRG).
RESULTS
AND D I S C U S S I O N
Initial
purification
of
the
acidic
rat
thymus
tissue
extract, preextracted by means of XAD-4 adsorbens resin, was carried out by Sephadex G-50 gelfiltration. tive ANP-like material sera) and
amounted eluted
as
obtained
to appoximately a
single
The immunoreac-
(determined by three 50 pg/mg wet
peak
with
a
tissue
molecular
corresponding to that of synthetic rat-pro-ANP
(2-126)
antiweight weight (data
not shown). The recovery of exogenous synthetic rat-ANP 126)
(i
pmol),
using
this
extraction
procedure, was 22%. In comparison, vein,
vena
and
rat atrium, rat pulmonary
cava and rat hypothalamus
contain
150, 0.6, 3 and 0.02 ng IR-ANP/mg wet tissue (14, 8, 15). 703
(2-
purification approximately , respectively
Vol. 155, No. 2, 1988 T77 o o~
BIOCHEMICAL AND BIOPHYSICALRESEARCHCOMMUNICATIONS
7
B
z zz
Ill
o i TONI
4O
III
I00
•~ o o . 99
.,oo[
,
< i
tl
i
A
55
./\
50 126
LOISL
1
>- C i
100
®
so 99 ~.. m
126
20
140
~
,200
55 GT-
23
+
70
' Q
2HN~ 1
99
....
/i\.
loo
126
20 15
25
"
35
20
fraction number FIGURE
30
trl i ~40
fraction number
1
Chromatoqraphic analysis of acidic extracts of rat thymus.
A)
RP-HPLC profiles monitored by three different antisera. A r r o w s i n d i c a t e t h e e l u t i o n p o s i t i o n of A N P A N P (i03-126), A N P (99-126) a n d A N P (2-126).
B)
Recognition employed.
c)
HP-GPC profiles obtained by use of the c o r r e s p o n d i n g antisera shown on the panel B. Elution positions of ANP (99-126) and ANP (2-126) are marked by arrows.
A verification
site
of
ANP
and analysis
(1-126)
by
applying
antisera
recognition tivity
2.
two
ANP-immunore-
approaches:
different
to monitor
chromatographic
sites
of
ANP-immunoreac-
separation
(Figure i, panel A) and HP-GPC
Figure
1 (panel A)
IR-ANP
material
antibodies.
distinctly
(1-126)
antisera
(Figure i, panel B).
conducting RP-HPLC
with
for ANP
the
of the endogenous
activity has been obtained by two different i.
(103-123),
shows
from
a GF
As illustrated
nize different
sites
the RP-HPLC run
(panel C).
profiles
detected
by
techniques
of the pooled
three
different
in panel B, these antisera
of the ANP molecule 704
(1-126):
recog-
Antiserum
Vol. 155, No. 2, 1988
"Toni
III"
molecule. However,
recognizes
the
crossreactivity
epitope
carboxy-terminal
It therefore crossreacts
Antiserum ANP
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
"Loisl"
with
(99-126),
the
100% with ANP
ANP
is apparently
of rat ANP
of
(1-126)
directed
was
ANP
(99-126). only
30%.
the
ring
against
but does not recognize human
(99-126). The synthetic precursor ANP
(2-126)
is detec-
ted to 48% by this antibody. In contrast,
antiserum
"GT-23"
does not recognize ANP well
(100%)
(13),
as
fragments
well
as
raised
against ANP
(99-126) at all. in the
the
region
It detects equally
from amino
rat-precursor
(11-37)
ANP
acid
(1-126)
1-98
molecule
(12). Using these three antisera for monitoring a RP-HPLC run of a thymus
extract
resulted
in
virtually
the
same
profile
(Figure i, A). The IR-ANP material eluted mainly in a single peak,
corresponding to synthetic rat-pro-ANP
rating
the
extracted
identified
IR-ANP
immunoreactivity
by
HP-GPC
possesses
weight as the synthetic rat-pro-ANP This
material
again
is
detected
the
same
(2-126)
by
(2-126). Sepa-
revealed
all
that
the
molecular
(Figure i, C). three
antisera.
Another peak of lower molecular weight is present when monitoring the run with antiserum "Loisl" and "GT-23",
respec-
tively.
product
It
most
likely
represents
a
degradation
lacking the intact carboxy-terminal of ANP
(1-126), because
it is not detected by antiserum "Toni III". Based
on
material
these which
results, seems
rat
thymus
contains
chromatographically
to
IR-ANP-Iike
represent
the
precursor ANP (1-126) molecule. Identifying
the
precursor-ANP molecule
in a tissue
raises
the question of whether this organ might also be the site of synthesis for the peptide, as it has been suggested for several other organs,
including the heart
(7, 8, 16). Ascri-
bing this putative ANP-precursor molecule to an anatomical localization distinct to the thymus would support this hypothesis. Immunohistochemical analysis of rat thymus sections, indeed, revealed ANP-immunopositive staining localized mainly in cells of the outer cortex sera
("Toni
III",
"Loisl"
the same staining pattern
and
(Figure 2). The three anti"GT-23")
showed
essentially
(data not shown). By using the N705
Vol. 155, No. 2, 1988
FIGURE
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2
Immunohistochemical analysis of rat thymus. The outer part of the cortex (c) of two thymus lobules separated by the connective tissue capsule (tc) is shown. Arrows mark representative immunopositive cells, most likely thymocytes. Their characteristic thin layer of cytoplasma is heavily stained by antiserum "GT-23" (x i000). terminally could
directed
exclude
ANP
(99-126)
the
precursor
does
not
antiserum
that
the
molecule
appear
to
experiments
cubated
with
synthetic
staining
has
staining
occured
with
(99-126)
antiserum 126)
(1-126)
circulate
is in
the
for immunopositive
The
prevailing
and
a much
staining
weaker
less the
with
rat
observed.
antiserum
As
"GT-23"
of
because
it
(12).
In
"GT-23"
almost
prein-
no
immuno-
expected,
immuno-
preincubated
This demonstrates
N-terminal
from
uptake
plasma
antiserum
2) we
result An
likely,
(2-126)
(results not shown).
requires
might
the thymus.
rat-ANP been
(shown in Figure
staining
outside
conducted
positive ANP
positive
synthesized
control
"GT-23"
sequence
of
with
that the
pro-ANP
(i-
staining. in the
immunoreaction 706
outer
cortex
in the
of
medulla
the
thymus
(data
not
Vol. 155, No. 2, 1988
shown)
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
suggest that most of the
represent
lymphoid cells
immunopositive cells might
(thymocytes),
being mainly
local-
ized in the cortical area and to a much lower degree in the medulla (17). Since light microscopy does not allow an exact identification
of
the
stained
cells,
electronmicroscopic
analysis is needed. Furthermore, thymocyte maturation occurs on the way
from the
cortex to the medulla
(18),
and thus
especially the outer cortical area contains mainly proliferating
cells
which
originate
from
the
bone
marrow
(19).
Therefore, the actual site of expression of ANP is difficult to ascribe. In
summary,
the
thymus,
representing
organ that generates T-cells ANP
(1-126).
This
finding
(20),
in
the
central
lymphoid
is suggested to express
context
that thymocytes bear receptors for ANP as to whether the atrial natriuretic
with
recent
reports
(9) evokes questions peptide might play a
role in the immune defence mechanisms.
ACKNOWLEDGEMENTS
We would like to thank Drs. M. Cantin and G. Thibault (Montreal, Canada) for providing the antiserum "GT-23" and especially for the support in establishing the RIA, Dr. R.M. Arendt (M~nchen, FRG) for donating the antiserum "Toni III", and Drs. Sch6ne, Preibisch and Seipke (Frankfurt, FRG) for providing the synthetic rat-ANP (2-126), Dr. Achmed Hassan (M~nchen, FRG) for his help performing the immunohistochemistry. The valuable support of Ms. A. Friedrich, G. Hach, D. Misera and U. R~berg and the secreterial assistance of Ms. B. Hilz is gratefully acknowledged. Supported by DFG (R.S.).
REFERENCES 1.
De Bold, A.J.
(1985) Science 230, 767-770.
2.
Cantin, M. and Genest, J. 127.
3.
Ruskoaho, Unger, T.
4.
Napier, M.A., Vandlen, R.L., Albers-Schonberg, G., Nutt, R.F.,Brady, S., Lyle, T., Winquist, R., Faison, E.P., Heinel, L.A. and Blaine, E.H. (1984) Proc. Natl. Acad. Sci. USA 81, 5946-5950.
(1985) Endocrin. Rev. 6, 107-
H., Lang, R.E., Toth, M., Ganten, D. and (1987) Eur. Heart J. 8, Suppl. B, 99-109.
707
Vol. 155, No. 2, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
5.
De Lean, A., P.W., Cantin, 2311-2318.
6.
Sakamoto, M., Nakao, K., Kihara, M., Morii, N., Sugawara, A., Suda, M., Shimkura, M., Kiso, Y., Yamori, Y. and Imura, H. (1985) Biochem. Biophys. Res. Commun. 128, 1281-1287.
7.
Ong, H., Lazure, C., Nguyen, T.T., McNicoll, N., Seidah, N., Chretien, M. and De Lean, A. (1987) Biochem. Biophys. Res. Commun. 147, 957-963.
8.
Asai, J., Nakazato, M., Toshimori, H., Matsukura, S., Kangawa, K. and Matsuo, H. (1987) Biochem. Biophys. Res. Commun. 146, 1465-1470.
9.
Kurihara, M., Katamine, S. and Saavedra, J.M. Biochem. Biophys. Res. Commun. 147, 789-796.
i0.
Bradford, M.
ii.
Arendt, R.M., Stangl, E., Zahringer, J., Liebisch, D.C. and Herz, A. (1985) FEBS Lett. 189, 57-61.
12.
Thibault, G., Murthy, K.K., Gutkowska, J., Seidah, N.G., Lazure, C., Chretien, M. and Cantin, M. (1988) Peptides 9, 47-53.
13.
Sundsfjord, J.A., Thibault, G., Larochelle, P. and Cantin, M. (1988) J. Clin. Endocr. Metab. 66, 605-610.
14.
Inscho, E.W., Wilfinger, W.W. Endocrinology 121, 1662-1670.
15.
Morii, N., Nakao, K., Sugawara, A., Sakamoto, M., Suda, M., Shimokura, M., Kiso, Y., Kihara, M., Yamori, Y., and Imura H. (1985) Biochem. Biophys. Res. Commun. 127, 413-419.
16.
Gutkowska, J., Cantin, M., Genest, (1987) FEBS Lett. 214, 17-20.
17.
Van Haelst, V.
(1967) Z. Zellforsch. 77, 534-549.
18.
Reinherz, 821-856.
and Schlossmann,
19.
Harris, J.E. and Ford, C.E.
20.
Stutman, O.
Gutkowska, J., M. and Genest,
McNicoll, J. (1984)
N., Schiller, Life Sci. 35,
(1987)
(1976) Anal. Biochem. 72, 248-249.
E.L.
and
Banks,
S.F.
J.
R.O.
and Sirois,
(1980).
Cell
P.
19,
(1964) Nature 201, 884-886.
(1978) Immunol. Rev. 42, 138-153.
708
(1987)